Company intelligence / Profile preview
SQZ Biotechnologies
Watertown, Massachusetts, United Statessqzbiotech.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
The company developed cell therapies using its proprietary Cell Squeeze technology. It had clinical trials for HPV16+ tumors but ultimately shut down operations in February 2024 after financial difficulties and the loss of its Roche partnership.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Cell therapies
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Roche (partnership ended in 2023)
Beyond the preview
Go deeper on SQZ Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SQZ Biotechnologies.